key: cord-0829454-f4c5ciza authors: Kronberg Jakobsen, K.; Schmidt Jensen, J.; Todsen, T.; Lippert, F.; Jean-Marie Martel, C.; Klokker, M.; von Buchwald, C. title: Detection of SARS-CoV-2 infection by rapid antigen test in comparison with RT-PCR in a public setting date: 2021-01-25 journal: nan DOI: 10.1101/2021.01.22.21250042 sha: 37cf027042a508685595885ebe55d83be0570b4b doc_id: 829454 cord_uid: f4c5ciza Background: Rapid and accurate detection of SARS-CoV-2 infection is essential in limiting the spread of infection during the ongoing COVID-19 pandemic. The aim of this study was to determine the accuracy of the STANDARD Q COVID-19 Ag test (SD BIOSENSOR) by comparison with RT-PCR in a public setting. Method: Individuals aged 18 years or older who had booked an appointment for a RT-PCR test on December 26-31, 2020 at a public test center in Copenhagen, Denmark, were invited to participate. An oropharyngeal swab was collected for RT-PCR analysis, immediately followed by a nasopharyngeal swab examined by the STANDARD Q COVID-19 Ag test (SD BIOSENSOR). Sensitivity, specificity, positive and negative predictive values of the antigen test were calculated with test results from RT-PCR as reference. Results: Overall, 4697 individuals were included (female n=2456, 53.3%; mean age: 44.7 years, SD: 16.9 years); 196 individuals were tested twice or more. Among 4811 paired conclusive test results from the RT-PCR and antigen tests, 221 (4.6%) RT-PCR tests were positive. The overall sensitivity and specificity of the antigen test were 69.7% and 99.5%, the positive and negative predictive values were 87.0% and 98.5%. Ct values were significantly higher among individuals with false negative antigen tests compared to true positives. Conclusion: The sensitivity, specificity, and predictive values found indicate that the STANDARD Q COVID-19 Ag is a good supplement to RT-PCR testing. Rapid and accurate detection of SARS-CoV-2 infection is essential in limiting the spread of infection during the ongoing COVID-19 pandemic. The cornerstone of SARS-CoV-2 testing is realtime reverse transcriptase-polymerase chain reaction (RT-PCR) of an upper-respiratory specimen. RT-PCR testing relies on centralized laboratory capacity and complex logistics, thus causing delays and bottlenecks with high sample numbers. Rapid antigen tests (RAT) can be performed onsite, are easy to administer, and the results are available within minutes. This enables an increased pace of testing and faster tracing of infected individuals. However, the accuracy of the RATs is questioned. The aim of this study was to determine the accuracy of the WHO EUL-approved STANDARD Q COVID-19 Ag test (SD BIOSENSOR) by comparison with RT-PCR in a public setting. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 25, 2021. ; Overall, 4697 individuals were included (female n=2456, 53.3%; mean age: 44.7 years, SD: 16.9 years); 196 individuals were tested twice or more. Paired conclusive test results from the RT-PCR tests and RAT were accessible for 4811 tests, of these 221 (4.6%) RT-PCR tests were positive; 97 RT-PCR tests were missing or inconclusive (i.e. Ct>38). The overall sensitivity and specificity of the RAT were 69.7% and 99.5%, the positive and negative predictive values were 87.0% and 98.5% (Table 1 ). Changing the criteria of positive RT-PCR to Ct£30 increased the sensitivity of the RAT to 81.1%. Among participants with self-reported symptoms and paired conclusive test results (n=705) the sensitivity and specificity of the RAT were 78.8% and 98.8%, and for participants without symptoms (n=3008) this was 49.2% and 99.6% (Table 1) . Ct values were significantly higher among individuals with false negative RATs compared to true positives ( Figure 1 ). This study comprises a non-selected population with a 4.6% prevalence of SARS-CoV-2 infection. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The comparison of test results from oropharyngeal and nasopharyngeal swabs suggests a limitation. However, both methods are in accordance with CDC recommendations 2 . Even though RT-PCR is considered the gold standard for detection of SARS-CoV-2 infection, it is not flawless, and the choice of RT-PCR as reference and criteria for positive results have implications 3, 4 . In agreement with WHO's recommendation of testing for SARS-CoV-2 as intensively as possible, the STANDARD Q COVID-19 Ag test and other RATs with similar accuracy seem to be a good supplement to RT-PCR testing 5 . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 25, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 25, 2021. ; Figure 1 : Difference in viral cycle threshold (Ct) value between participants with positive and negative rapid antigen tests among RT-PCR-positive participants with and without self-reported symptoms (n=144). Analysis for statistical difference was performed by Wilcoxon test. Abbreviations: Symptoms+ = individuals with self-reported symptoms, Symptoms-= individuals without self-reported symptoms, RAT+ = positive rapid antigen test, RAT-= negative rapid antigen test . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 25, 2021. The WHO EUL-approved STANDARD Q COVID-19 Ag test produced by SD BIOSENSOR was performed by personnel from the private company Copenhagen Medical A/S and conducted according to SD BIOSENSOR's instructions immediately after the oropharyngeal swab for RT-PCR testing. Participants with non-conclusive RAT tests had a new test performed before leaving the test center until a conclusive result was obtained. Upon agreeing to participate in the study the participants mobile phone number was registered and link to an online questionnaire was sent by SMS. The questionnaire was developed in REDCap and the participants' answers were collected here as well. The questions included if the participant: 1. had previously tested positive for COVID-19 2. had been in close contact with a known infected individuals If yes was answered to the third question, the participants were asked which symptoms and for how long he or she had symptoms prior to the test. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 25, 2021. ; https://doi.org/10.1101/2021.01.22.21250042 doi: medRxiv preprint The study followed the Helsinki II Declaration, and all participants gave informed consent. Approval for conducting the study was obtained from the Regional Committee on Health Research Ethics (case nr. 20083631) and the Danish Data Protection Agency (P-2020-1222). . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 25, 2021. ; https://doi.org/10.1101/2021.01.22.21250042 doi: medRxiv preprint Center for Disease Control and Prevention. Interim Guidance for Antigen Testing for SARS-CoV-2 Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19 Ct values and infectivity of SARS-CoV-2 on surfaces Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection We thank Copenhagen Medical A/S for delivering the rapid antigen tests and providing test personnel for performing the tests. We thank Andreas Lyman and the personnel at Testcenter Taastrup for their essential assistance in collecting data. Last, we thank Martin Magelund Rasmussen, Anne-Marie Vangsted, and Nikolai Søren Kirkby for critical discussion and help with